Skip to main content
The British Journal of General Practice logoLink to The British Journal of General Practice
. 2001 Jun;51(467):473–477.

Topical antibiotics for acute bacterial conjunctivitis: a systematic review.

A Sheikh 1, B Hurwitz 1
PMCID: PMC1314030  PMID: 11407054

Abstract

There has been uncertainty about whether antibiotic therapy confers significant benefit in the treatment of acute bacterial conjunctivitis. This study aimed to assess the efficacy of antibiotic therapy in the management of acute bacterial conjunctivitis. Using standard Cochrane search methods, we identified double-blind randomised controlled trials in which any form of antibiotic treatment (topical, systemic or combination) had been compared with placebo in the management of acute bacterial conjunctivitis. Data extraction and analysis followed a pre-defined protocol. Meta-analysis was performed to obtain summary measures of relative risk. Six published trials were identified, of which three fulfilled the eligibility criteria for inclusion in this review. The trials were heterogeneous in terms of their inclusion and exclusion criteria, the nature of the intervention, and the outcome measures assessed. Meta-analysis indicates that acute bacterial conjunctivitis is frequently a self-limiting condition, as clinical remission occurred by days 2 to 5 in 64% (95% confidence interval (CI) = 57-71) of those treated with placebo. Treatment with antibiotics was, however, associated with significantly better rates of clinical remission (days 2 to 5: relative risk (RR) = 1.31, 95% CI = 1.11-1.55), with a suggestion that this benefit was maintained for late clinical remission (days 6 to 10: RR = 1.27, 95% CI = 1.00-1.61). Acute bacterial conjunctivitis is frequently a self-limiting condition but the use of antibiotics is associated with significantly improved rates of early clinical remission, and early and late microbiological remission. Since trials to date have been conducted in selected specialist care patient populations, generalisation of these results to a primary care-based population should be undertaken with a degree of caution.

Full Text

The Full Text of this article is available as a PDF (72.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Behrens-Baumann W., Quentin C. D., Gibson J. R., Calthrop J. G., Harvey S. G., Booth K. Trimethoprim-polymyxin B sulphate ophthalmic ointment in the treatment of bacterial conjunctivitis: a double-blind study versus chloramphenicol ophthalmic ointment. Curr Med Res Opin. 1988;11(4):227–231. doi: 10.1185/03007998809114240. [DOI] [PubMed] [Google Scholar]
  2. Chaudhry N. A., Flynn H. W., Jr, Murray T. G., Tabandeh H., Mello M. O., Jr, Miller D. Emerging ciprofloxacin-resistant Pseudomonas aeruginosa. Am J Ophthalmol. 1999 Oct;128(4):509–510. doi: 10.1016/s0002-9394(99)00196-8. [DOI] [PubMed] [Google Scholar]
  3. Dart J. K. Eye disease at a community health centre. Br Med J (Clin Res Ed) 1986 Dec 6;293(6560):1477–1480. doi: 10.1136/bmj.293.6560.1477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fitch C. P., Rapoza P. A., Owens S., Murillo-Lopez F., Johnson R. A., Quinn T. C., Pepose J. S., Taylor H. R. Epidemiology and diagnosis of acute conjunctivitis at an inner-city hospital. Ophthalmology. 1989 Aug;96(8):1215–1220. doi: 10.1016/s0161-6420(89)32749-7. [DOI] [PubMed] [Google Scholar]
  5. Genée E., Schlechtweg C., Bauerreiss P., Gibson J. R. Trimethoprim-polymyxin eye drops versus neomycin-polymyxin-gramicidin eye drops in the treatment of presumptive bacterial conjunctivitis - a double-blind study. Ophthalmologica. 1982;184(2):92–96. doi: 10.1159/000309190. [DOI] [PubMed] [Google Scholar]
  6. Gibson J. R. Trimethoprim-polymyxin B ophthalmic solution in the treatment of presumptive bacterial conjunctivitis--a multicentre trial of its efficacy versus neomycin-polymyxin B-gramicidin and chloramphenicol ophthalmic solutions. J Antimicrob Chemother. 1983 Mar;11(3):217–221. doi: 10.1093/jac/11.3.217. [DOI] [PubMed] [Google Scholar]
  7. Gigliotti F., Hendley J. O., Morgan J., Michaels R., Dickens M., Lohr J. Efficacy of topical antibiotic therapy in acute conjunctivitis in children. J Pediatr. 1984 Apr;104(4):623–626. doi: 10.1016/s0022-3476(84)80566-1. [DOI] [PubMed] [Google Scholar]
  8. Gigliotti F., Williams W. T., Hayden F. G., Hendley J. O., Benjamin J., Dickens M., Gleason C., Perriello V. A., Wood J. Etiology of acute conjunctivitis in children. J Pediatr. 1981 Apr;98(4):531–536. doi: 10.1016/s0022-3476(81)80754-8. [DOI] [PubMed] [Google Scholar]
  9. Goldstein M. H., Kowalski R. P., Gordon Y. J. Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review. Ophthalmology. 1999 Jul;106(7):1313–1318. [PubMed] [Google Scholar]
  10. Heggie A. D. Incidence and etiology of conjunctivitis in Navy recruits. Mil Med. 1990 Jan;155(1):1–3. [PubMed] [Google Scholar]
  11. Horton R. Evidence and primary care. Lancet. 1999 Feb 20;353(9153):609–610. doi: 10.1016/S0140-6736(99)00056-2. [DOI] [PubMed] [Google Scholar]
  12. Hvidberg J. Fusidic acid in acute conjunctivitis. Single-blind, randomized comparison of fusidic acid and chloramphenicol viscous eye drops. Acta Ophthalmol (Copenh) 1987 Feb;65(1):43–47. doi: 10.1111/j.1755-3768.1987.tb08489.x. [DOI] [PubMed] [Google Scholar]
  13. Hørven I. Acute conjunctivitis. A comparison of fusidic acid viscous eye drops and chloramphenicol. Acta Ophthalmol (Copenh) 1993 Apr;71(2):165–168. doi: 10.1111/j.1755-3768.1993.tb04983.x. [DOI] [PubMed] [Google Scholar]
  14. Jauch A., Fsadni M., Gamba G. Meta-analysis of six clinical phase III studies comparing lomefloxacin 0.3% eye drops twice daily to five standard antibiotics in patients with acute bacterial conjunctivitis. Graefes Arch Clin Exp Ophthalmol. 1999 Sep;237(9):705–713. doi: 10.1007/s004170050300. [DOI] [PubMed] [Google Scholar]
  15. Lancaster T., Swart A. M., Jick H. Risk of serious haematological toxicity with use of chloramphenicol eye drops in a British general practice database. BMJ. 1998 Feb 28;316(7132):667–667. doi: 10.1136/bmj.316.7132.667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Leibowitz H. M. Antibacterial effectiveness of ciprofloxacin 0.3% ophthalmic solution in the treatment of bacterial conjunctivitis. Am J Ophthalmol. 1991 Oct;112(4 Suppl):29S–33S. [PubMed] [Google Scholar]
  17. Leibowitz H. M., Pratt M. V., Flagstad I. J., Berrospi A. R., Kundsin R. Human conjunctivitis. II. Treatment. Arch Ophthalmol. 1976 Oct;94(10):1752–1756. doi: 10.1001/archopht.1976.03910040526011. [DOI] [PubMed] [Google Scholar]
  18. Little P., Williamson I., Warner G., Gould C., Gantley M., Kinmonth A. L. Open randomised trial of prescribing strategies in managing sore throat. BMJ. 1997 Mar 8;314(7082):722–727. doi: 10.1136/bmj.314.7082.722. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lohr J. A., Austin R. D., Grossman M., Hayden G. F., Knowlton G. M., Dudley S. M. Comparison of three topical antimicrobials for acute bacterial conjunctivitis. Pediatr Infect Dis J. 1988 Sep;7(9):626–629. doi: 10.1097/00006454-198809000-00005. [DOI] [PubMed] [Google Scholar]
  20. Mahajan V. M. Acute bacterial infections of the eye: their aetiology and treatment. Br J Ophthalmol. 1983 Mar;67(3):191–194. doi: 10.1136/bjo.67.3.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Malminiemi K., Kari O., Latvala M. L., Voutilainen R., Miettinen A., Jauch A. Topical lomefloxacin twice daily compared with fucidic acid in acute bacterial conjunctivitis. Acta Ophthalmol Scand. 1996 Jun;74(3):280–284. doi: 10.1111/j.1600-0420.1996.tb00092.x. [DOI] [PubMed] [Google Scholar]
  22. McDonnell P. J. How do general practitioners manage eye disease in the community? Br J Ophthalmol. 1988 Oct;72(10):733–736. doi: 10.1136/bjo.72.10.733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Miller I. M., Wittreich J., Vogel R., Cook T. J. The safety and efficacy of topical norfloxacin compared with placebo in the treatment of acute, bacterial conjunctivitis. The Norfloxacin-Placebo Ocular Study Group. Eur J Ophthalmol. 1992 Apr-Jun;2(2):58–66. doi: 10.1177/112067219200200202. [DOI] [PubMed] [Google Scholar]
  24. Morrow G. L., Abbott R. L. Conjunctivitis. Am Fam Physician. 1998 Feb 15;57(4):735–746. [PubMed] [Google Scholar]
  25. Perkins R. E., Kundsin R. B., Pratt M. V., Abrahamsen I., Leibowitz H. M. Bacteriology of normal and infected conjunctiva. J Clin Microbiol. 1975 Feb;1(2):147–149. doi: 10.1128/jcm.1.2.147-149.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Stern G. A., Killingsworth D. W. Complications of topical antimicrobial agents. Int Ophthalmol Clin. 1989 Fall;29(3):137–142. doi: 10.1097/00004397-198902930-00001. [DOI] [PubMed] [Google Scholar]
  27. Trimethoprim-polymyxin B sulphate ophthalmic ointment versus chloramphenicol ophthalmic ointment in the treatment of bacterial conjunctivitis--a review of four clinical studies. The Trimethoprim-Polymyxin B Sulphate Ophthalmic Ointment Study Group. J Antimicrob Chemother. 1989 Feb;23(2):261–266. doi: 10.1093/jac/23.2.261. [DOI] [PubMed] [Google Scholar]
  28. Wiholm B. E., Kelly J. P., Kaufman D., Issaragrisil S., Levy M., Anderson T., Shapiro S. Relation of aplastic anaemia to use of chloramphenicol eye drops in two international case-control studies. BMJ. 1998 Feb 28;316(7132):666–666. doi: 10.1136/bmj.316.7132.666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. van Rensburg S. F., Gibson J. R., Harvey S. G., Burke C. A. Trimethoprim-polymyxin ophthalmic solution versus chloramphenicol ophthalmic solution in the treatment of bacterial conjunctivitis. Pharmatherapeutica. 1982;3(4):274–277. [PubMed] [Google Scholar]

Articles from The British Journal of General Practice are provided here courtesy of Royal College of General Practitioners

RESOURCES